Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7265)
All Articles published online
|
Publishing Process of This Article
|
Oct 10, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jacobsen B, Kriegbaum MC, Santoni-Rugiu E, Ploug M. C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma. World J Clin Oncol 2014; 5(4): 621-632 [PMID: 25302166 DOI: 10.5306/wjco.v5.i4.621] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i4/621.htm |
| Number | Citing Articles |
| 1 |
M. A. Shulepko, M. L. Bychkov, M. P. Kirpichnikov, E. N. Lyukmanova. Recombinant SLURP-1 Inhibits Growth and Migration of U251 MG Glioma by Cell Cycle Arrest and Modulation of MAPK and AKT Signaling Pathways. Russian Journal of Bioorganic Chemistry 2023; 49(4): 768 doi: 10.1134/S1068162023040180
|
| 2 |
M. A. Shulepko, M. L. Bychkov, M. P. Kirpichnikov, E. N. Lyukmanova. Recombinant SLURP-1 Inhibits Growth and Migration of U251 MG Glioma by Cell Cycle Arrest and Modulation of MAPK and AKT Signaling Pathways. Биоорганическая химия 2023; 49(4): 403 doi: 10.31857/S0132342323040401
|
| 3 |
Tingting Hu, Yingjie Zhang, Tianqing Yang, Qingnan He, Mingyi Zhao. LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.795820
|
| 4 |
Allison S. Cohen, Farah K. Khalil, Eric A. Welsh, Matthew B. Schabath, Steven A. Enkemann, Andrea Davis, Jun-Min Zhou, David C. Boulware, Jongphil Kim, Eric B. Haura, David L. Morse. Cell-surface marker discovery for lung cancer. Oncotarget 2017; 8(69): 113373 doi: 10.18632/oncotarget.23009
|
| 5 |
Michael Gruet, Daniel Cotton, Clare Coveney, David Boocock, Sarah Wagner, Lucie Komorowski, Robert Rees, A. Pockley, A. Garner, John Wallis, Amanda Miles, Desmond Powe. β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3. Biology 2020; 9(2): 39 doi: 10.3390/biology9020039
|
| 6 |
Magdalena Görtz, Uwe Galli, Thomas Longerich, Margot Zöller, Ulrike Erb, Peter Schemmer. De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells. Oncology Reports 2017; 38(5): 2697 doi: 10.3892/or.2017.5980
|
| 7 |
Godfrey Essien Etokebe, Shanbeh Zienolddiny, Zeljko Kupanovac, Morten Enersen, Sanja Balen, Veljko Flego, Ljiljana Bulat-Kardum, Anđelka Radojčić-Badovinac, Vidar Skaug, Per Bakke, Aage Haugen, Zlatko Dembic, Qing-Yi Wei. Association of the FAM46A Gene VNTRs and BAG6 rs3117582 SNP with Non Small Cell Lung Cancer (NSCLC) in Croatian and Norwegian Populations. PLOS ONE 2015; 10(4): e0122651 doi: 10.1371/journal.pone.0122651
|
| 8 |
Benedikte Jacobsen, Danielle Larouche, Olivier Rochette-Drouin, Michael Ploug, Lucie Germain. Expression of C4.4A in an In Vitro Human Tissue-Engineered Skin Model. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/2403072
|